Merck Newsroom Home
Description
pulled from site's meta descriptionMerck's online newsroom allows journalists, consumers and investors to find real-time news about Merck's prescription medicines, vaccines and consumer care products.
Domain Resolution
This domain resolves to the following IP addresses:This is an automatically generated AboutUs page for Mercknewsroom.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- Merck Newsroom
- Merck Investor Relations
- Merck Events
- Merck Press Release
- Merck Corporate Responsibility
- Merck Social Media
- Merck Vaccines
- Merck Prescription medicine
- Merck Research
- Merck Pipeline
- Merck Consumer Care
- Merck Media Contacts
- NYSE: MRK
- Merck Earnings
- Merck Animal Health
- Merck Foundation
- Merck For Mothers
- Zetia
- Vytorin
- Integrilin
- Januvia
- Janumet
- Cozaar/Hyzaar
- Zocor
- Propecia
- Claritin Rx
- Remeron
- juvisync
- Proscar
- Isentress
- Cancidas
- PegIntron
- Primaxin
- Invanz
- Avelox
- Noxafil
- zioptan
- Crixivan/Stocrin
- Victrelis
- Maxalt
- Cosopt/Trusopt
- Temodar
- Emend
- Intron A
- Singulair
- Remicade
- Nasonex
- Clarinex
- Arcoxia
- Simponi
- Asmanex
- Proventil
- Dulera
- Fosamax
- NuvaRing
- Follistim AQ
- Implanon
- Cerazette
- Claritin OTC
- Coppertone
- ProQuad
- M-M-R II
- Varivax
- Gardasil
- RotaTeq
- Zostavax
- Pneumovax
- Dr. Scholls
- Merck Patience assistance program
- Merck Annual Report
- Merck Careers/Jobs
- Kenneth C. Frazier
- Adam Schechter
- Michael Rosenblatt
- Peter N. Kellogg
- Peter S. Kim
- Julie Gerberding
- Tredaptive
- Suvorexant
- Odanacateb
- V503
- Bridion